Drug recall · December 4, 2019
Lidocaine HCl Injection recall
Why: Presence of Foreign Substance: Foreign material found inside the vial.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Lidocaine HCl Injection, USP, 2% 100 mg/5 mL (20 mg/mL), Preservative-Free, packaged in 10 x 5 mL Single Dose Vials per carton, Rx only, Distributed by: AuroMedics Pharma LLC, 279 Princeton-Hightstown Rd., E. Windsor, NJ 08520, NDC 55150-165-05.
- Lots / codes
Batch #: CLC190049, Exp 02/2022
- Quantity
- 111,850 vials
- Company
- AuroMedics Pharma LLC, East Windsor, NJ
- Distribution
- Nationwide in the USA
- Initiated
- November 11, 2019 · Voluntary: Firm initiated
- Classified
- December 5, 2019
- Reported
- December 4, 2019
- Ended
- November 17, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lidocaine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.